Salute e Benessere

Why Regular Blood Pressure Monitoring Could Save Your Life: A Look into the…

Why Regular Blood Pressure Monitoring Could Save Your Life: A Look into the Future of Home Healthcare
Transparency Market Research
20/05/2025

Regenics AS completes second tranche of private placement to continue…

"We are excited that Nordic Blue with their experience and success in the field of wound care continue to believe and are willing to support Regenics in the further development of Collex®," said Jan A. Alfheim, Board Chair of Regenics. "Their investment and participation at the board level have been of great value this past year and we look forward to continuing our successful collaboration." "We are excited that Nordic Blue with their experience and success in the field…
PR Newswire
20/05/2025

Maren Thurow starts as new Head Global Communications at Grünenthal

Maren joined Grünenthal in 2021 as Head of Global Commercial Communication and was subsequently the Planning Director for the company's commercial organization. Prior to joining Grünenthal Maren was a Director at FleishmanHillard, one of the world's leading global PR firms. Maren joined Grünenthal in 2021 as Head of Global Commercial Communication and was subsequently the Planning Director for the company's commercial organization. Prior to joining Grünenthal Maren was a Director at...
PR Newswire
20/05/2025

BioFlag Showcases Innovative Probiotic Solutions at Vitafoods Europe 2025

Key innovations include: Key innovations include: Bifidobacterium animalis subsp. lactis BL-99, sourced from their Chinese maternal-infant probiotic strain library. BL-99 holds 12 Chinese invention patents covering gut health, immune regulation, and bone health, and is widely used in infant formula, yogurt, and dietary supplements. Lactobacillus paracasei K56, isolated from the gut of healthy Chinese infants and clinically proven to reduce body fat, visceral fat, and waist circumference...
PR Newswire
20/05/2025

Pulnovo Medical Welcomes EQT as a New Investor Following CE-MDR Approval, with…

Founded in 2013, Pulnovo Medical addresses a critical unmet need in cardiovascular care by developing a first-in-class medical device based on pulmonary artery denervation (PADN) core technology. It was awarded US FDA Breakthrough Device designation in 2021 and FDA Humanitarian Use Device designation in 2023. Its catheter and generator received China NMPA Approval as a breakthrough device in late 2023, followed by FDA clearance of the 9F sheath in 2024. In March 2025, the company obtained CE-MDR…
PR Newswire
20/05/2025

Johnny's Chop Shop Unveils Volume & Texture Powder - The Ultimate Styling Hack…

With men ranking texture as the second most desired hair benefit, according to a recent Mintel study, Johnny's Chop Shop has crafted a lightweight, high-performance powder that helps to deliver instant body, grip, and definition. Tried, tested, and developed by master barbers, Volume & Texture Powder gets the job done with a lightweight feel and minimal effort required. With men rankingtexture as the second most desired hair benefit, according to a recent Mintel study, Johnny's Chop Shop...
PR Newswire
20/05/2025

Lupin and Honeywell Move Forward Jointly with Plans for HFO Technology in…

NEW DELHI and MUMBAI, India, May 20, 2025 /PRNewswire/ -- Global pharma major Lupin Limited (Lupin) announced today its plan to use Honeywell's Solstice® Air (HFO-1234ze cGMP) propellant to transform respiratory care through the development of next-generation inhalers. Designed for patients with asthma and chronic obstructive pulmonary disease (COPD), Honeywell Solstice Air has the potential to prevent the release of high global warming potential (GWP) molecules, marking a major step forward in…
PR Newswire
20/05/2025

Over 4 in 5 Brits fail to connect tea with these 5 science-backed health…

This year it coincides with the publishing of a new real-world research survey[1] of over 1,000 Brits, reviewed by the Tea Advisory Panel (TAP; www.teaadvisorypanel.com). The survey results shine a harsh light on our lack of knowledge of the health benefits of regular tea drinking, with over four in five Brits failing to make the link between their daily cuppa and benefits to their heart health, brain health, bone health, mental health, and sleep. This year it coincides with the publishing of…
PR Newswire
20/05/2025

Baxter launches HEMOPATCH Sealing Hemostat, a room-temperature collagen pad…

The performance of Hemopatch Sealing Hemostat involves the interaction of two components that can create rapid and lasting hemostasis by sealing off the bleeding surface. The white, tissue-facing side of Hemopatch Sealing Hemostat is covered with a thin layer of NHS-PEG. The NHS-PEG, when in contact with blood or other body fluids forms a hydrogel which enhances its adhering properties and seals the tissue surface. In contact with blood, collagen induces aggregation of platelets. Platelets…
PR Newswire
20/05/2025

AB Science announces the successful completion of a EUR 1.8 million private…

PRESS RELEASEAB SCIENCE ANNOUNCES THE SUCCESSFUL COMPLETION OF A EUR 1.8 MILLION PRIVATE PLACEMENTParis, May 20, 2025, 8am AB Science S.A. (the “ Company ” or “ AB Science ”, Euronext – FR0010557264 – AB) announces today the successful completion of a capital increase of a total gross amount of EUR 1.8 million subscribed by a limited number of investors (the “ Private Placement ”).The Private Placement is not subject to a prospectus requiring an approval from the French Financial...
Nasdaq GlobeNewswire
20/05/2025

CROSSJECT prepares for the launch of a capital increase with preferential…

Press ReleaseCROSSJECT prepares for the launch of a capital increase with preferential subscription rights of around 5 million euros in preparation for commercial and production activities linked to EUA approvalThe amount of the proposed transaction (“the Offer”) might be increased to around 5.8 million euros if the extension clause is exercised;Gemmes Venture, the Company's reference shareholder, announced its intention to guarantee the capital increase in cash up to the amount...
Nasdaq GlobeNewswire
20/05/2025

MediThinQ Enters China Through Strategic Partnership with Sinopharm, Making…

A major milestone in MediThinQ's global commercialisation was achieved through an exclusive distribution agreement with a leading global medtech company, first in the US and later in Europe. Building on this momentum, the partnership with Sinopharm fills the final major gap in its global footprint by accelerating adoption in China's vast healthcare system. A major milestone in MediThinQ's global commercialisation was achieved through an exclusive distribution agreement with a leading global...
PR Newswire
20/05/2025

Basilea announces commercial availability of antibiotic Zevtera® (ceftobiprole)…

Allschwil, Switzerland, May 20, 2025 Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial and fungal infections, announced today that its antibiotic Zevtera ®(ceftobiprole medocaril for injection) is now commercially available in the United States through Basilea's partner Innoviva Specialty Therapeutics, Inc., a wholly owned subsidiary of Innoviva, Inc. (NASDAQ: INVA). Zevtera is used...
Nasdaq GlobeNewswire
20/05/2025

Intra-tumoral Cancer Therapies Market to Show Tremendous Growth at a CAGR of…

Key Takeaways from the Intra-tumoral Cancer Therapies Market Report Key Takeaways from the Intra-tumoral Cancer Therapies Market Report Discover which therapies are expected to grab the intra-tumoral cancer therapies market share @ Intra-tumoral Cancer Therapies Market Report Intra-tumoral Cancer Therapies Market Dynamics The intra-tumoral cancer therapies market dynamics are expected to change in the coming years. Various classes of intra-tumoral immunotherapies, including...
PR Newswire
19/05/2025

Zymeworks Presents Preclinical Data on ZW1528 at the American Thoracic Society…

Company's first development candidate in autoimmune and inflammatory disease (AIID) demonstrates potent blockade of IL-4, IL-13, and IL-33 signaling pathways critical in respiratory inflammationNovel bispecific design shows promising potential manufacturability and stability to support high dosing concentration and subcutaneous administrationRegulatory filing to support Phase 1 studies expected in 2H-2026 VANCOUVER, British Columbia, May19, 2025(GLOBE NEWSWIRE) -- Zymeworks Inc...
Nasdaq GlobeNewswire
19/05/2025

Regenics AS appoints Jostein Grip as new CEO

Karin Gilljam, who has served as interim CEO for Regenics, will return to her role as company CSO and will be an integral part of the Regenics management team along with Jostein. Karin Gilljam, who has served as interim CEO for Regenics, will return to her role as company CSO and will be an integral part of the Regenics management team along with Jostein. "We believe Jostein is an excellent choice for the CEO role and that he will be a strong addition to the Regenics team." saidJan…
PR Newswire
19/05/2025

Eurobio Scientific: EB Development rises above 90% threshold

EB Development rises above 90% thresholdParis, May 19, 2024 – 7:00 pm - Eurobio Scientific(FR0013240934, ALERS, PEA-PME eligible), a leading French group inin vitromedical diagnostics and life sciences, was informed today by EB Development that it had exceeded the threshold of 90% of the company's share capital. This threshold crossing results from the acquisition by EB Development of Eurobio Scientific shares on the market.EB Development now holds 9,224,652 shares, or 90...
Nasdaq GlobeNewswire
19/05/2025

IBA – ACQUISITION OF OWN SHARES

Immediate Release – May 19 th, 2025 Louvain-la-Neuve, Belgium, May 19 th, 2025 -In accordance with article 8:4 of the Royal Decree of 29 April 2019 executing the Belgian Code on Companies and Associations, Ion Beam Applications SA (“IBA”) hereby discloses information in relation to its share buyback program announced on March 24 th, 2025. Under this program, IBA has requested a financial intermediary to repurchase up to 650,000 IBA ordinary shares on its behalf under the terms of...
Nasdaq GlobeNewswire
19/05/2025

Spineway : Combined General Meeting of June 4, 2025 - Availability of…

Press release Ecully, May 19, 2025 – 6.30 p.m. SPINEWAYCombined General Meeting of June 4, 2025 Availability of preparatory documents Spineway informs its shareholders that they are invited to attend the Combined General Meeting to be held onWednesday, June 4, 2025 at 2:00 p.m. at the Group's headquarters, 7 allée Moulin Berger in Ecully (69).The notice of meeting, which is valid as a notice of convocation, including the agenda and the text of the resolutions...
Nasdaq GlobeNewswire
19/05/2025

Global phase III trials demonstrate that nerandomilast slowed lung function…

Nerandomilast, an investigational agent, met the primary endpoint of both phase III trials, FIBRONEER™-IPF and FIBRONEER™-ILD, significantly reducing the decline in forced vital capacity (FVC) [mL] by absolute change from baseline at week 52, compared to placebo. 1,2 Nerandomilast's safety and tolerability profile was consistent across both trials, with similar rates of permanent treatment discontinuation to placebo. 1,2 In both trials the composite key secondary endpoint (time to...
Nasdaq GlobeNewswire
19/05/2025

Sterile Filtration Market is expected to generate a revenue of USD 20.76 Billion…

The sterile filtration market is witnessing steady growth driven by its critical role in pharmaceutical, food & beverage, and biotechnology sectors to ensure contamination-free production processes. The sterile filtration market is witnessing steady growth driven by its critical role in pharmaceutical, food & beverage, and biotechnology sectors to ensure contamination-free production processes. Key Highlights of the Report : Why This Report Matters : This report delivers...
PR Newswire
19/05/2025

Dental Air Polishing and Ultrasonics Market to Reach $3.5 Billion by 2035…

For more comprehensive insights, download the FREE report sample: https://www.meticulousresearch.com/download-sample-report/cp_id=6174 For more comprehensive insights, download the FREE report sample:https://www.meticulousresearch.com/download-sample-report/cp_id=6174 Key Market Drivers and Trends The dental air polishing and ultrasonics market is experiencing significant growth due to the shift towards combination systems and focus on biocompatible polishing powders that are...
PR Newswire
19/05/2025

Transactions in Connection with Share Buy-back Program

Company Announcement COPENHAGEN, Denmark; May 19, 2025 – Genmab A/S (Nasdaq: GMAB).On March 25, 2025, Genmab announced the initiation of a share buy-back program to repurchase up to 2.2 million shares to reduce capital and to honor our commitments under the Restricted Stock Unit program. The share buy-back program is expected to be completed no later than July 10, 2025.The following transactions were executed under the program from May 12 to May 16, 2025: Trading PlatformNo...
Nasdaq GlobeNewswire
19/05/2025

Shanton to Present Topline Data from Phase 2b Study with SAP-001 in Refractory…

EULAR, the European Alliance of Associations for Rheumatology holds its annual congress in Barcelona from June 11-14, 2025. The EULAR review committee and board have now accepted Shanton's late-breaking abstract on the outcomes of Shanton's phase 2b study in refractory gout patients with its lead investigational drug SAP-001. Late-breaking abstracts that are accepted for oral presentation at the annual congress are defined by EULAR as "highly significant and timely findings in…
PR Newswire
19/05/2025
Altri  Comunicati